31 Jul
2013

Patent protection for human genes ends in the US

In Myriad the Supreme Court excluded
naturally occurring DNA, such as genes,
from the scope of patent protection. It is
not yet clear what impact the decision
will have and that very uncertainty is
fuelling concern throughout the medical
and biotech industries